Bdenza Enzalutamide 40MG Tablets are non-steroidal antiandrogen agents that are used for treatment of prostate cancer. They are known to be highly effective for treating metastatic castration-resistant prostate cancer in combination with castration. These tablets are metabolized in liver by CYP2C8 and CYP3A4 with protein binding ability of 97 to 98%. Bdenza Enzalutamide 40MG Tablets are selective silent androgen receptor antagonists. They are second generation NSAA for having increased efficiency as an antiandrogen as compared to first generation compounds.
Highly effective in nature
Eliminated via bile and urine
Produces carboxylic acid derivatives as inactive metabolites
Developed and Managed by Infocom Network Private Limited.